| Vaccine | Antibody response | Protection against disease | Dose | Most common side effects | Contraindications |
| MMR | Single dose: 0.5 mL SC Second dose if required: 0.5 mL SC at least 28 days later | Most rare after revaccination Fever, rash Lymphadenopathy Febrile seizures Allergic reactions Thrombocytopenia Arthritis, arthralgias | Pregnancy current or planned within 28 days Immunocompromised (refer to related UpToDate topics) Anaphylaxis after eating eggs or receiving neomycin Recent administration of immune globulin (delay vaccine administration for at least six months after intramuscular administration or eight months after intravenous administration) | ||
| Measles | 99 percent (after 2 doses) | 99 percent - Lifelong | |||
| Mumps | 97 percent (after 1 dose) | 75 to 95 percent >30 years | |||
| Rubella | 95 percent (after 1 dose) | 90 percent >15 years ? lifelong | |||
